Skip to content

One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy

Treatment of Basal Cell Carcinoma Using a One-stop-shop With Reflectance Confocal Microscopy : a Randomized Controlled Multicenter Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21856
Enrollment
76
Registered
2015-08-09
Start date
2015-02-03
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal cell carcinoma (BCC)

Interventions

Conventional surgical excision under local anesthetics

Sponsors

Academic Medical Center (AMC) Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinically suspected new primary BCC as assessed by an experienced board certified dermatologist Patients seen at the outpatient clinic before 12h00 AM will be eligible to participate Patient is willing and able to give written informed consent BCC lesion is suitable for conventional surgical excision under local anesthetics BCC lesion is present since at least 1 month

Exclusion criteria

Exclusion criteria: BCC lesion in a high-risk location of the face (H-zone and ears) Contra-indication for conventional surgical excision (primary surgical closure seems not achievable) Recurrent BCC lesion (BCC that has been previously unsuccessfully treated) Macroscopic ulcerating BCC lesions (not feasible for RCM analysis due to technical reasons) Patients with basal cell nevus syndrome Patients treated with hedgehog inhibitor medication Patients with a history of hypersensitivity to and/ or a history of allergy to local anesthesia Unavailability within the following 6 weeks (for example due to holiday or sports) Patients not competent to understand the procedures involved

Design outcomes

Primary

MeasureTime frame
Comparison between one stop shop using reflectance confocal microscopy in the surgical treatment of BCC and current standard of care using punch biopsy, by assessing incomplete surgical excision on the final pathology report.

Secondary

MeasureTime frame
Comparison of the diagnostic accuracy (sensitivity and specificity) between RCM and punch biopsy in both diagnosing and subtyping BCCs [ Time Frame: Within the first week after surgical excision of suspected BCC lesion ] [ Designated as safety issue: No ] Sensitivity and specificity of RCM for diagnosing and subtyping BCC, will be separately analyzed by comparing RCM diagnosis and subtype with final pathology reports of the study group. This will be performed by using unidentifiable saved RCM images of all included lesions of the study group. Comparison of patient satisfaction between study group and standard of care (control) group by using a standardized web-based questionnaire for patient reported outcome in the management of skin diseases (www.huidvragen.info) [ Time Frame: As assessed at the post-operative visit 3 months after surgical excision ] [ Designated as safety issue: No ] An adjusted version of this web-based questionnaire has previously been published to assess patient satisfaction among patients suffering from psoriasis (van Cranenburgh OD et al. Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol. 2013 Aug;169(2):398-405). The outcome of the questionnaire will be compared between study- and control group.

Contacts

Public ContactDaniel J. Kadouch

Academic Medical Center (AMC) - Department of dermatology

d.j.kadouch@amc.nl+31 20 5662587

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)